^○田中 薫¹, 宮脇 太一², 釼持 広知², 原田 英幸², 大出 泰久², 千葉 康敬², 土井 啓至², 田中 謙太郎², 松本 圭司², 大島 理規², 三浦 理², 小久保 雅樹², 戸井 之裕², 東 公一², 山口 正史², 岡本 勇², 中川 和彦², 山本 信之² (1.近畿大学医学部内科学腫瘍内科部門, 2.西日本がん研究機構（WJOG）)

^○Joachim Aerts¹, Luis Paz-Ares², Carole Helissey³, Frederico Cappuzzo⁴, Gilles Quere⁵, Dariusz Kowalski⁶, Jose Carlos Benitez⁷, Florian Guisier⁸, Benjamin Besse⁹, Gadgeel Shirish¹⁰, Wehler Thomas¹¹, Ignacio Gil-Bazo¹², Michael J. Chisamore¹³, Cem Gorgun¹⁴, Ilhan Celik¹⁵, Marie Holst Morch¹⁶, Patricia Garrido Castro¹⁷, Teng Jin Ong¹⁸, Enriqueta Felip¹⁹ (1.Erasmus MC, Rotterdam, Netherlands, 2.Hospital Universitario 12 de Octubre, Madrid, Spain, 3.Military Hospital Begin, Saint-Mand?, France, 4.IFO Regina Elena, Rome, Italy, 5.Hopital Morvan CHU de Brest, Brest, France, 6.The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland, 7.Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Biomedical Research Institute of M?laga（IBIMA BIONAND Platform）, M?laga, Spain, 8.Normandie Univ, UNIROUEN, LITIS Lab QuantIF team EA4108, CHU Rouen, Department of Pneumology and Inserm CIC-CRB 1404, F-76000 Rouen, France, 9.Gustave Roussy, Villejuif, France, 10.Henry Ford Cancer Institute, Detroit, USA, 11.Universitatsklinik Gie?en und Marburg, Standort Gie?en, Marburg, Germany, 12.Fundacion Instituto Valenciano de Oncologia, Valencia, Spain, 13.Merck ＆ Co., Inc., Rahway, USA, 14.BioNTech US Inc., Cambridge, USA, 15.BioNTech SE, Mainz, Germany, 16.Genmab, Copenhagen, Denmark, 17.Genmab, Utrecht, Netherlands, 18.Genmab, Plainsboro, USA, 19.Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain)

^○和久井 大¹, 堀池 篤², 菅原 俊一³, 峯岸 裕司⁴, 田坂 定智⁵, 酒谷 俊雄⁶, 鈴木 弘行⁷, 細見 幸生⁸, 丹保 裕一⁹, 下川 恒生¹⁰, 宮内 栄作¹¹, 猶木 克彦¹², 福原 達朗¹³, 竹ノ下 祥子¹⁴, 井上 永介¹⁵, 和田 聡^2,14, 吉村 清^2,14, 相良 博典¹⁶, 小林 真一¹⁴, 角田 卓也² (1.東京慈恵会医科大学呼吸器内科, 2.昭和大学腫瘍内科, 3.仙台厚生病院呼吸器内科, 4.三井記念病院呼吸器内科, 5.弘前大学呼吸器内科, 6.NTT東日本関東病院呼吸器内科, 7.福島県立医科大学呼吸器外科, 8.都立駒込病院呼吸器内科, 9.金沢大学呼吸器内科, 10.横浜市立市民病院呼吸器内科, 11.東北大学病院呼吸器内科, 12.北里大学呼吸器内科, 13.宮城県立がんセンター呼吸器内科, 14.昭和大学臨床薬理研究所, 15.昭和大学統括研究推進センター, 16.昭和大学呼吸器アレルギー内科)

^○Ryo Ariyasu¹, Luis Paz-Ares², Federico Cappuzzo³, Noboru Yamamoto⁴, Natalie Vokes⁵, Jhanelle E. Gray⁶, Taofeek Owonikoko⁷, Hidenobu Ishii⁸, Jin Hyoung Kang⁹, Se-Hoon Lee¹⁰, Roland Hallwachs¹¹, Anna Coenen-Stass¹¹, Barbara Sarholz¹¹, Linda Pudelko¹¹, Jatinder Kaur Mukker¹², Camilo Moulin¹³, Ioannis Gounaris¹⁴, Liza C. Villaruz¹⁵ (1.Cancer Institute Hospital of JFCR, Tokyo, Japan, 2.Hospital Universitario 12 de Octubre, Madrid, Spain, 3.Azienda Unità Sanitaria Locale, AUSL della Romagna, Ravenna, Italy, 4.National Cancer Center Hospital, Tokyo, Japan, 5.The University of Texas, MD Anderson Cancer Center, Houston, USA, 6.Moffitt Cancer Center, Tampa, USA, 7.University of Pittsburgh, Pittsburgh, USA, 8.Kurume University Hospital, Kurume, Japan, 9.Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea, 10.Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, 11.Merck Healthcare KGaA, Darmstadt, Germany, 12.EMD Serono Research ＆ Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA, 13.Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, 14.Merck Serono Ltd., Feltham, UK, an affiliate of Merck KGaA, 15.UPMC Hillman Cancer Center, Pittsburgh, PA, USA)

^○Yuki Sato¹, Yoko Tani², Hidenobu Ishii³, Seigo Katakura⁴, Masahide Oki⁵, Yasutaka Watanabe⁶, Toshihide Yokoyama⁷, Katsuhiko Naoki⁸, Jean-Francois Pouliot⁹, Anne Paccaly⁹, Eric Kim⁹, Jayakumar Mani⁹, Siyu Li⁹, Israel Lowy⁹, Frank Seebach⁹, Melissa Mathias⁹, Satoshi Ikeda¹⁰ (1.Kobe City Medical Center General Hospital, 2.Osaka Metropolitan University Hospital, 3.Kurume University Hospital, 4.Kanagawa Cancer Center, 5.National Hospital Organization Nagoya Medical Center, 6.Saitama Cancer Center, 7.Kurashiki Central Hospital, 8.Kitasato University Hospital, 9.Regeneron Pharmaceuticals, Inc., 10.Kanagawa Cardiovascular and Respiratory Center)